There are 2934 resources available
Should we incorporate immunotherapy in early breast cancer?
Presenter: Rebecca Dent
Session: Tackling the diversity of triple negative early breast cancer (TNBC)
Resources:
Slides
Webcast
Geriatric Oncology: The contribution of Arti Hurria
Presenter: Silvio Monfardini
Session: ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities
Resources:
Slides
Webcast
Introduction
Presenter: Demetris Papamichael
Session: ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities
Resources:
Slides
Webcast
Frailty: Concept, biology, assessment and corrective measures
Presenter: Siri Rostoft
Session: ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities
Resources:
Slides
Webcast
Setting up genomic tumour boards: What can be done and what needs to be done?
Presenter: Scott Tomlins
Session: Genomic tumour boards to deliver better prostate cancer care
Resources:
Slides
Webcast
Cancer stem cells: Are they a valid therapeutic target?
Presenter: Simone Niclou
Session: Glioblastoma treatment: Where should the future lead?
Resources:
Slides
Webcast
2111 - Phase III randomized study of neoadjuvant chemotherapy (CT) with docetaxel(D), oxaliplatin(O) and S-1(S) (DOS) followed by surgery and adjuvant S-1, vs surgery and adjuvant S-1, for resectable advanced gastric cancer (GC) (PRODIGY)
Presenter: Yoon-Koo Kang
Session: Proffered Paper 2 – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Proffered Paper 2 – Gastrointestinal tumours, non-colorectal - Invited Discussant LBA43 and LBA44
Presenter: Kei Muro
Session: Proffered Paper 2 – Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Conclusions
Presenter: Siri Rostoft
Session: ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities
Resources:
Slides
An overview of immunotherapy in older patients
Presenter: Ravindran Kanesvaran
Session: ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities
Resources:
Slides